Amneal launches Fylnetra biosimilarFylnetra is used to treat neutropenia, which is commonly experienced by patients undergoing chemotherapy. Upsher-Smith intros dicyclomine hydrochloride capsulesUpsher-Smith now offers dicyclomine hydrochloride in tablet and capsule forms. U.S. Supreme Court rejects Teva challenge to $235M GSK award in patent dispute over generic drugs involving Coreg The case involves "skinny labels," which allow generic drugmakers to avoid patent lawsuits if a generic drug's label omits potentially infringing uses of a brand-name drug, per a Reuters report. Aurobindo receives FDA nod for generic Dibenzyline Phenoxybenzamine hydrochloride capsules are indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating. Aurigene Pharmaceutical Services expands biologics CDMO capacity Aurigene is investing $40 million in an R&D and pilot scale facility as a first step toward a series of strategic investments. Alembic intros Docetaxel injection Docetaxel injection is a microtubule inhibitor indicated for treating patients with several types of cancer after failure of prior chemotherapy. Sandoz inks multi-year partnership with Just - Evotec Biologics Sandoz and Just - Evotec Biologics are partnering to develop and manufacture multiple biosimilars with an option for expansion. Aurobindo receives FDA OK for generic Furadantin Nitrofurantoin oral suspension is indicated for the treatment of certain urinary tract infections. Alvotech joins forces with Polifarma for proposed biosimilar Eylea Polifarma will commercialize AVT06, a proposed biosimilar to Eylea, in Turkey. Generic sterile injectables market to reach $196.2B by 2029 A growing prevalence of chronic diseases has become a significant factor in target market growth, per a report from Prophecy Market Insights. First Previous 49 50 51 52 53 Next Last